Andrea V. Barrio - Concepedia

Author

Andrea V. Barrio

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

A Barrio, A. Barrio, A. V. Barrio, A.V. Barrio, Andrea V. Barrio, Andrea Barrio, Andrea V Barrio, Andrea V. Barrio, Andrea Veronica Barrio

135

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Bryn Mawr Hospital Drexel University University of Basel Brigham and Women's Hospital

About

Andrea V. Barrio is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	30	1.7K
2	Health Sciences	12	12	367
3	Engineering	2	2	77
4	Biomedical Engineering	1	1	59
5	Geriatrics	1	1	16

Andrea V. Barrio

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study Anita Mamtani, Andrea V. Barrio, Tari A. King, Annals of Surgical Oncology Surgical OncologyMedicineCancer ManagementSurgical PathologyBreast Cancer	2016	303
Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast Andrea V. Barrio, Bradly D. Clark, Jessica Goldberg, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineSurgical PathologyPathology	2007	250
Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Tracy‐Ann Moo, Marcia Edelweiss, Sabina Hajiyeva, Annals of Surgical Oncology Surgical OncologySentinel NodeNeoadjuvant ChemotherapyMedicineInterventional Radiology	2018	158
Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare Event Andrea V. Barrio, Giacomo Montagna, Anita Mamtani, JAMA Oncology	2021	142
Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers Monica Morrow, Kimberly J. Van Zee, Sujata Patil, Annals of Surgery	2017	108
MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer Joseph J. Weber, Maxine S. Jochelson, Anne Eaton, Journal of the American College of Surgeons	2017	102
How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery? Oriana Petruolo, Varadan Sevilimedu, Giacomo Montagna, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineCancer ManagementBreast Cancer	2020	97
Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema Giacomo Montagna, Jennifer Zhang, Varadan Sevilimedu, JAMA Oncology	2022	96
Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy Giacomo Montagna, Anita Mamtani, Andrea Knežević, Annals of Surgical Oncology Surgical OncologyMedicineBreast CancerCancer TreatmentOncology	2020	82
A Randomized Prospective Comparison of Patient‐Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization Erica V. Bloomquist, Nicolás Ajkay, Sujata Patil, The Breast Journal Surgical OncologyPatient‐assessed SatisfactionCancer ManagementSurgeryTreatment Verification	2015	78

Page 1